These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9117020)

  • 1. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
    Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA
    Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
    Lehnigk B; Rabe KF; Dent G; Herst RS; Carpentier PJ; Magnussen H
    Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.
    Wenzel SE; Trudeau JB; Kaminsky DA; Cohn J; Martin RJ; Westcott JY
    Am J Respir Crit Care Med; 1995 Sep; 152(3):897-905. PubMed ID: 7663802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
    Hui KP; Taylor IK; Taylor GW; Rubin P; Kesterson J; Barnes NC; Barnes PJ
    Thorax; 1991 Mar; 46(3):184-9. PubMed ID: 1851340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Dahlén B; Kumlin M; Ihre E; Zetterström O; Dahlén SE
    Thorax; 1997 Apr; 52(4):342-7. PubMed ID: 9196517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.
    Meltzer SS; Hasday JD; Cohn J; Bleecker ER
    Am J Respir Crit Care Med; 1996 Mar; 153(3):931-5. PubMed ID: 8630575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.
    Bronsky EA; Kemp JP; Zhang J; Guerreiro D; Reiss TF
    Clin Pharmacol Ther; 1997 Nov; 62(5):556-61. PubMed ID: 9390112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.
    Melillo E; Woolley KL; Manning PJ; Watson RM; O'Byrne PM
    Am J Respir Crit Care Med; 1994 May; 149(5):1138-41. PubMed ID: 8173753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms.
    Manning PJ; Watson RM; O'Byrne PM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):950-4. PubMed ID: 8214949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma.
    Mickleborough TD; Lindley MR; Ionescu AA; Fly AD
    Chest; 2006 Jan; 129(1):39-49. PubMed ID: 16424411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.
    Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L
    Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
    Nasser SM; Bell GS; Hawksworth RJ; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP
    Thorax; 1994 Aug; 49(8):743-8. PubMed ID: 8091317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide.
    Taylor DA; McGrath JL; O'Connor BJ; Barnes PJ
    Am J Respir Crit Care Med; 1998 Jul; 158(1):99-106. PubMed ID: 9655713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative contributions of histamine and prostanoids to bronchoconstriction provoked by isocapnic hyperventilation in asthma.
    Finnerty JP; Harvey A; Holgate ST
    Eur Respir J; 1992 Mar; 5(3):323-30. PubMed ID: 1572446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Yoshida S; Amayasu H; Sakamoto H; Onuma K; Shoji T; Nakagawa H; Tajima T
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.